GSK plc EBITDA for the year ending December 31, 2024: USD 8.35 B

GSK plc EBITDA is USD 8.35 B for the year ending December 31, 2024, a -28.17% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
  • GSK plc EBITDA for the year ending December 31, 2023 was USD 11.63 B, a 11.49% change year over year.
  • GSK plc EBITDA for the year ending December 31, 2022 was USD 10.43 B, a -0.64% change year over year.
  • GSK plc EBITDA for the year ending December 31, 2021 was USD 10.50 B, a -24.37% change year over year.
  • GSK plc EBITDA for the year ending December 31, 2020 was USD 13.88 B, a 11.70% change year over year.
Key Data
Date EBITDA Net Income EPS (Diluted) Shares (Diluted, Weighted)